Literature DB >> 17039328

[The German program for disease management guidelines. Background, methods, and development process].

Günter Ollenschläger1, Ina Kopp, Monika Lelgemann, Sylvia Sänger, Lothar Heymans, Henning Thole, Henrike Trapp, Wilfried Lorenz, Hans-Konrad Selbmann, Albrecht Encke.   

Abstract

The Program for National Disease Management Guidelines (German DM-CPG Program) was established in 2002 by the German Medical Association (umbrella organization of the German Chambers of Physicians) and joined by the Association of the Scientific Medical Societies (AWMF; umbrella organization of more than 150 professional societies) and by the National Association of Statutory Health Insurance Physicians (NASHIP) in 2003. The program provides a conceptual basis for disease management, focusing on high-priority health-care topics and aiming at the implementation of best practice recommendations for prevention, acute care, rehabilitation and chronic care. It is organized by the German Agency for Quality in Medicine, a founding member of the Guidelines International Network (G-I-N). The main objective of the German DM-CPG Program is to establish consensus of the medical professions on evidence-based key recommendations covering all sectors of health-care provision and facilitating the coordination of care for the individual patient through time and across interfaces. Within the last year, DM-CPGs have been published for asthma, chronic obstructive pulmonary disease, type 2 diabetes, and coronary heart disease. In addition, experts from national patient self-help groups have been developing patient guidance based upon the recommendations for health-care providers. The article describes background, methods, and tools of the DM-CPG Program, and is the first of a publication series dealing with innovative recommendations and aspects of the program.

Entities:  

Mesh:

Year:  2006        PMID: 17039328     DOI: 10.1007/s00063-006-1114-9

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  6 in total

1.  [Perspectives in guideline development and implementation in Germany].

Authors:  I B Kopp
Journal:  Z Rheumatol       Date:  2010-06       Impact factor: 1.372

Review 2.  Development of Quality Management Systems for Clinical Practice Guidelines in Korea.

Authors:  Heui-Sug Jo; Dong Ik Kim; Sung-Goo Chang; Ein-Soon Shin; Moo-Kyung Oh
Journal:  J Korean Med Sci       Date:  2015-10-16       Impact factor: 2.153

3.  [Aims of the guidelines for diagnostic and treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Eich; R Schmale-Grete; W Häuser
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

4.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

Review 5.  [Fibromyalgia--the new guideline].

Authors:  W Brückle
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

6.  Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline.

Authors:  Winfried Häuser; Bernhard Arnold; Wolfgang Eich; Eva Felde; Christl Flügge; Peter Henningsen; Markus Herrmann; Volker Köllner; Edeltraud Kühn; Detlev Nutzinger; Martin Offenbächer; Marcus Schiltenwolf; Claudia Sommer; Kati Thieme; Ina Kopp
Journal:  Ger Med Sci       Date:  2008-12-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.